The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 03, 2018

Filed:

Apr. 04, 2013
Applicant:

Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);

Inventors:

Vikas P. Sukhatme, Newton, MA (US);

Jian-Guo Ren, West Roxbury, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/225 (2006.01); A61K 33/24 (2006.01); A61K 45/06 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/225 (2013.01); A61K 33/24 (2013.01); A61K 45/06 (2013.01); C12N 15/1137 (2013.01); G01N 33/5008 (2013.01); C12N 2310/14 (2013.01); C12N 2320/31 (2013.01); G01N 2500/04 (2013.01); G01N 2800/7023 (2013.01);
Abstract

The present invention relates to methods, compositions, and diagnostic tests for treating and diagnosing proliferative disorders, such as cancel-, that result in dysregulation of malic enzyme 2. In particular, the methods and compositions include monotherapy with malate, or a derivative thereof, as well as combination therapy, such as malate, or a derivative thereof, combined with another therapeutic agent, such as a malic enzyme 2 inhibitor, an antineoplastic agent, a glycolysis inhibitor, an antiangiogenic agent, an immunomodulatory agent, an antibody, or a cytokine.


Find Patent Forward Citations

Loading…